What is Selzentry (maraviroc)?
Selzentry is a prescription antiviral medicine (generic name: maraviroc) used to treat HIV-1 infection in certain adults, as part of antiretroviral therapy. It works by blocking HIV from entering CD4+ T cells by binding to the CCR5 receptor on those cells.
When is Selzentry used, and who can take it?
Selzentry is generally used for people whose HIV strain uses the CCR5 co-receptor to enter cells (often described as “CCR5-tropic” HIV). It is not a one-size-fits-all HIV drug; if HIV uses a different entry pathway, other treatments are typically needed.
How is Selzentry taken?
Selzentry is taken by mouth, in tablet form, usually twice daily. The exact dose can depend on other medicines being used and on kidney function.
Drug interactions: what medicines can affect Selzentry?
Selzentry dosing can change when it’s used with certain drugs that affect how the body processes maraviroc (for example, some strong enzyme inducers or inhibitors). Patients should not start or stop other medications without checking for interactions.
What are common side effects people ask about?
Commonly reported side effects can include dizziness, nausea, diarrhea, fatigue, headache, and cough. As with other HIV medicines, serious adverse effects are possible, and any new or worsening symptoms should be discussed with a clinician.
Is Selzentry still under patent, and who makes it?
DrugPatentWatch tracks patent and exclusivity information for branded products such as Selzentry. You can check the latest status there: DrugPatentWatch - Selzentry.
If you meant something specific (price, generic, dosing, or alternatives)
“Selzentry” alone can refer to different needs. Tell me what you’re looking for—such as:
- current cost / generic availability,
- exact dosing for a particular kidney function or interacting medicine,
- side-effect details for a specific symptom,
- comparison vs other HIV drugs,
and I’ll tailor the answer to that.
Sources
- DrugPatentWatch - Selzentry